Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 5, Pages e19423
Publisher
Public Library of Science (PLoS)
Online
2011-05-18
DOI
10.1371/journal.pone.0019423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease
- (2010) Jukka Westerbacka et al. GASTROENTEROLOGY
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
- (2010) Eric J Topol et al. LANCET
- Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice
- (2009) Jitske de Vries-van der Weij et al. ATHEROSCLEROSIS
- Analytical strategies in lipidomics and applications in disease biomarker discovery
- (2009) Chunxiu Hu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- CETP does not affect triglyceride production or clearance inAPOE*3-Leidenmice
- (2009) Silvia Bijland et al. JOURNAL OF LIPID RESEARCH
- The Metabolic Syndrome
- (2009) Matthew V. Potenza et al. NUTRITION IN CLINICAL PRACTICE
- Metabolic Profiling of the Response to an Oral Glucose Tolerance Test Detects Subtle Metabolic Changes
- (2009) Suzan Wopereis et al. PLoS One
- Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients
- (2009) Juergen Graessler et al. PLoS One
- Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins
- (2008) Sandrin C. Bergheanu et al. CURRENT MEDICAL RESEARCH AND OPINION
- Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study †
- (2008) Luc F. Van Gaal et al. EUROPEAN HEART JOURNAL
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- RPLC-Ion-Trap-FTMS Method for Lipid Profiling of Plasma: Method Validation and Application to p53 Mutant Mouse Model
- (2008) Chunxiu Hu et al. JOURNAL OF PROTEOME RESEARCH
- High Throughput Lipidomic Profiling of Schizophrenia and Bipolar Disorder Brain Tissue Reveals Alterations of Free Fatty Acids, Phosphatidylcholines, and Ceramides
- (2008) Emanuel Schwarz et al. JOURNAL OF PROTEOME RESEARCH
- Systematic review of school-based interventions that focus on changing dietary intake and physical activity levels to prevent childhood obesity: an update to the obesity guidance produced by the National Institute for Health and Clinical Excellence
- (2008) T. Brown et al. Obesity Reviews
- Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
- (2007) Willeke de Haan et al. ATHEROSCLEROSIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started